|Description||These mRNAs are produced by in vitro transcription and stabilized at the 5’ end by modified nucleotides capping (Cap1). These mature mRNA contain a poly(A) tail at the 20’ end and are also optimized to yield improved stability and performance.|
|Benefits||Protein expression directly in cytoplasm without nuclear uptake; faster protein expression than DNA transfection; no genome integration; protein expression directly related to mRNA amount; ideal for transfecting slow or non-dividing cells; The protein is expressed by means of a promoter.|
|Applications||R-Luc mRNA, have been designed to produce high expression level of Renilla Luciferase protein.|
For research use only. Not intended for any clinical use.